121 related articles for article (PubMed ID: 35636337)
1. Identification of potential inhibitors against FemX of Staphylococcus aureus: A hierarchial in-silico drug repurposing approach.
Rahman S; Rajak K; Mishra S; Das AK
J Mol Graph Model; 2022 Sep; 115():108215. PubMed ID: 35636337
[TBL] [Abstract][Full Text] [Related]
2. Targeting Staphylococcal Cell-Wall Biosynthesis Protein FemX Through Steered Molecular Dynamics and Drug-Repurposing Approach.
Rahman S; Nath S; Mohan U; Das AK
ACS Omega; 2023 Aug; 8(32):29292-29301. PubMed ID: 37599983
[No Abstract] [Full Text] [Related]
3. Drug Repurposing Approach for Developing Novel Therapy Against Mupirocin-Resistant
Mujwar S; Deshmukh R; Harwansh RK; Gupta JK; Gour A
Assay Drug Dev Technol; 2019 Oct; 17(7):298-309. PubMed ID: 31634019
[No Abstract] [Full Text] [Related]
4. Structure-Based Identification of Potential Drugs Against FmtA of Staphylococcus aureus: Virtual Screening, Molecular Dynamics, MM-GBSA, and QM/MM.
Dalal V; Dhankhar P; Singh V; Singh V; Rakhaminov G; Golemi-Kotra D; Kumar P
Protein J; 2021 Apr; 40(2):148-165. PubMed ID: 33421024
[TBL] [Abstract][Full Text] [Related]
5. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
Mahey N; Tambat R; Chandal N; Verma DK; Thakur KG; Nandanwar H
Microbiol Spectr; 2021 Dec; 9(3):e0095121. PubMed ID: 34908453
[TBL] [Abstract][Full Text] [Related]
6. Integrated Multi-omics, Virtual Screening and Molecular Docking Analysis of Methicillin-Resistant
Rahman S; Das AK
Int J Pept Res Ther; 2021; 27(4):2735-2755. PubMed ID: 34548853
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
[TBL] [Abstract][Full Text] [Related]
8. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
[TBL] [Abstract][Full Text] [Related]
9. Effects of ketamine in methicillin-resistant
Coutinho TDNP; Barroso FDD; da Silva CR; da Silva AR; Cabral VPF; Sá LGDAV; Cândido TM; da Silva LJ; Ferreira TL; da Silva WMB; Silva J; Marinho ES; Cavalcanti BC; Moraes MO; Nobre Júnior HV; Andrade Neto JB
Can J Microbiol; 2021 Dec; 67(12):885-893. PubMed ID: 34314621
[TBL] [Abstract][Full Text] [Related]
10. Exploring species-specific inhibitors with multiple target sites on
Yuce M; Sarica Z; Ates B; Kurkcuoglu O
J Biomol Struct Dyn; 2023 May; 41(8):3496-3510. PubMed ID: 35302925
[TBL] [Abstract][Full Text] [Related]
11. Systematic identification and repurposing of FDA-approved drugs as antibacterial agents against Streptococcus pyogenes: In silico and in vitro studies.
Gracia J; Perumal D; Dhandapani P; Ragunathan P
Int J Biol Macromol; 2024 Feb; 257(Pt 2):128667. PubMed ID: 38101681
[TBL] [Abstract][Full Text] [Related]
12. Targeting human thymidylate synthase: Ensemble-based virtual screening for drug repositioning and the role of water.
Mteremko D; Chilongola J; Paluch AS; Chacha M
J Mol Graph Model; 2023 Jan; 118():108348. PubMed ID: 36257147
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Chan EWL; Yee ZY; Raja I; Yap JKY
J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking, binding free energy calculation and molecular dynamics simulation studies of benzothiazol-2-ylcarbamodithioates as
Jupudi S; Azam MA; Wadhwani A
J Recept Signal Transduct Res; 2019 Jun; 39(3):283-293. PubMed ID: 31538846
[TBL] [Abstract][Full Text] [Related]
15. Molecular docking, dynamics simulation and pharmacokinetic studies of
Swain A; Choudhir G; Prabakaran D; Hariprasad P
J Biomol Struct Dyn; 2023 Nov; 41(19):9245-9255. PubMed ID: 36373334
[No Abstract] [Full Text] [Related]
16. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Molecular Docking Studies and Antibacterial Activities of Novel Monocationic Indole-benzimidazole Derivatives.
Ates-Alagoz Z; Kisla MM; Goker H; Yildiz S
Med Chem; 2021; 17(7):699-706. PubMed ID: 32310051
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of
Dissanayake DMIH; Perera DDBD; Keerthirathna LR; Heendeniya S; Anderson RJ; Williams DE; Peiris LDC
J Biomol Struct Dyn; 2022 Apr; 40(7):3273-3284. PubMed ID: 33213303
[TBL] [Abstract][Full Text] [Related]
19. Modulating the antibacterial effect of the existing antibiotics along with repurposing drug metformin.
Hossain S; Rafi RH; Ripa FA; Khan MRI; Hosen ME; Molla MKI; Faruqe MO; Al-Bari MAA; Das S
Arch Microbiol; 2024 Mar; 206(4):190. PubMed ID: 38519821
[TBL] [Abstract][Full Text] [Related]
20. Finding the First Potential Inhibitors of Shikimate Kinase from Methicillin Resistant
Rios-Soto L; Téllez-Valencia A; Sierra-Campos E; Valdez-Solana M; Cisneros-Martínez J; Gómez Palacio-Gastélum M; Castillo-Villanueva A; Avitia-Domínguez C
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
